927
Participants
Start Date
May 28, 2018
Primary Completion Date
January 15, 2026
Study Completion Date
December 4, 2026
Ocrelizumab
Ocrelizumab will be administered via intravenous (IV) infusion at an initial dose of two 300-mg infusions separated by 14 days (on Days 1 and 15), and then 600 mg at every subsequent dose every 24 weeks for the remainder of the study treatment period (approximately 192 weeks)
Beaumont Hospital, Dublin
Semmelweis Egyetem AOK, Budapest
VALEOMED Diagnosztikai Központ, Esztergom
Rigshospitalet, Glostrup Municipality
Jósa András Oktatókórház, Nyíregyháza
Hjerne- og nervesygdomme, Ambulatorium, Skleroseklinikken, Sønderborg
Pécsi Tudományegyetem, Klinikai Központ Neurológiai Klinika, Pécs
Aarhus Universitetshospital, Aarhus N
Hopital Cheikh Zaid, Rabat
Azienda Sanitaria Ospedaliera S. Luigi Gonzaga, Orbassano
Hopital Militaire d'Instruction Mohamed V, Rabat
Hospital Clínica Biblica, San José
AOU Città della Salute e della Scienza, Turin
Ain Shams University Hospital, Cairo
The MS Center of Northeastern New York, Latham
CHU de la Timone - Hopital d Adultes, Marseille
CHU De Caen, Caen
Unidad de investigacion en salud (UIS), Mexico City
Irccs A.O.U.San Martino Ist, Genoa
Universitätsmedizin Greifswald, Greifswald
University of Pennsylvania, Philadelphia
IRCCS Ospedale San Raffaele, Milan
Fond. Istituto Neurologico C.Besta, Milan
Clinical Research Center-Alex university, Alexandria
Studienzentrum Nordwest Dr med Joachim Springub Herr Wolfgang Schwarz, Westerstede
IRCCS Istituto Neurologico C. Mondino?Dip. Neurologia Neuroriabilitazione S.S. Sclerosi Multipla, Pavia
Centre Hospitalier Universitaire Hassan II, Fes
GroupeHospitalo-Universitaire Caremeau, Nîmes
Groupe Hospitalier Pellegrin, Bordeaux
University of South Florida, Tampa
Ospedale Cattinara, Trieste
Hopital Gui de Chauliac, Montpellier
Centre Hospitalier Universitaire de Rennes, Rennes
Policlinico G.B. Rossi, Verona
Neurology Clinic PC, Cordova
Hopital Nord Laennec, Nantes
Cleveland Clinic Mellen Center, Cleveland
University of Cincinnati, Cincinnati
Hospital Universitario la Fe, Valencia
Wayne State University School of Medicine, Detroit
AOUC Azienda Ospedaliero-Universitaria Careggi, Florence
CHRU Nancy, Nancy
Nemocnice Jihlava, Jihlava
Hopital B Roger Salengro, Lille
Hopital Gabriel Montpied CHU de Clermont-Ferrand, Clermont-Ferrand
Washington University School of Medicine, St Louis
CHIC Cote Basque Bayonne, Bayonne
Deutsche Klinik für Diagnostik, Wiesbaden
Hopitaux Universitaires de Strasbourg, Strasbourg
Hopital neurologique Pierre Wertheimer - CHU Lyon, Bron
Azienda Ospedaliero Universitaria Consorziale Policlinico di, Bari
NeuroConcept AG C/O mind mvz GmbH, Stuttgart
Clinical Center University of Sarajevo, Sarajevo
University Clinical Center Tuzla, Tuzla
University Clinical Center of the Republic of Srpska, Banja Luka
Lone Star Neurology of San Antonio, San Antonio
Central Texas Neurology Consultants, Round Rock
A. O. U. Federico II, Napoli
Università degli Studi della Campania Luigi Vanvitelli, Napoli
Università degli studi della Campania Luigi Vanvitelli, Napoli
CHU Amiens Hopital Sud, Salouël
IRCCS Istituto Neurologico Neuromed, Pozzilli
University Hospital Mostar, Mostar
NeuroPoint Gesellschaft fur vorbeugende Gesundheitspflege mbH, Ulm
SC3 Research Group, Inc, Pasadena
MS Center of California, Laguna Hills
University of California San Francisco, San Francisco
AOU Policlinico V. Emanuele - P.O G. Rodolico, Catania
Swedish Multiple Sclerosis Center, Seattle
Cleveland Clinic Abu Dhabi, Abu Dhabi
Jusupovskaya Hospital, Moscow
Scientific Neurology Center, Moscow
City Clinical Hospital #24, Moskva
Vladimirskiy Regional Scientific Research Inst., Moscow
National Center of Social Significant Disease, Saint Petersburg
Yale University, North Haven
University of Chicago, Chicago
Massachusetts General Hospital, Boston
Dragonfly Research, LLC, Wellesley
Instituto de Neurologia de Curitiba, Curitiba
Hospital Sao Lucas - PUCRS, Porto Alegre
Hospital das Clínicas Faculdades Médicas de Ribeirão Preto, Ribeirão Preto
Hospital das Clinicas - FMUSP_X, São Paulo
Fraser Health Authority - Fraser Health Multiple Sclerosis, Burnaby
University of British Columbia Hospital, Vancouver
London Health Sciences Centre Uni Campus, London
St. Michael'S Hospital, Toronto
Recherche Sepmus Inc., Greenfield Park
Hospital Notre-Dame du Centre Hospitalier de l'Universite de Montreal, Montreal
Saskatoon City Hospital, Saskatoon
Organizacion Sanitas Internacional, Bogotá
Fundacion Clinica Valle del Lili, Santiago de Cali
Cork University Hospital, Cork
Lebanese American University Medical Center- Rizk Hospial, Beirut
Consultorios Médicos PaItilla, Panama City
Hospital Universitario Virgen de Arrixaca, Murcia
Rashid hospital, Dubai
Fakultní Nemocnice Olomouc, Olomouc
Fakultni nemocnice Ostrava, Ostrava-Poruba
Vseobecna fakultni nemocnice v Praze, Prague
Hôpital Pasteur, Nice
"Universitätsklinikum Carl Gustav Carus, Zentrum für Klinische Neurowissenschaften", Dresden
Nucare, Guatemala City
St Vincents University Hospital, Dublin
Policlinico Tor Vergata Dip. Neuroscienze-Clinica Neurologica-UOSD Sclerosi Multipla, Rome
Policlinico Universitario A. Gemelli, Rome
A.O. Sant'Andrea, Rome
Azienda Ospedaliera Sant'Andrea, Rome
Ospedale Binaghi, Cagliari
American University of Beirut - Medical Center, Beirut
Grupo Medico de Investigacion Clinica Multidisciplinaria, Mexico City
Clinstile S.A de C.V., Mexico City
Hospital General de Mexico, Mexico
Amphia Ziekenhuis, Breda
Catharina ziekenhuis, Eindhoven
Maasstadziekenhuis, NL -rotterdam
Zuyderland Medisch Centrum - Sittard Geleen, Sittard-Geleen
Uniwersytecki Szpital Kliniczny w Bialymstoku, Bialystok
Szpital Uniwersytecki w Krakowie, Krakow
Centrum Neurologii Krzysztof Selmaj, Lodz
SP Swiecickiego UM Marcinkowskiego, Późna
"Centrum Medyczne MEDYK", Rzeszów
Wojskowy Instytut Medyczny - Pa?Stwowy Instytut Badawczy, Warsaw
SPSK nr 1, Zabrze
Hospital Vall d'Hebron, Barcelona
Hoffmann-La Roche
INDUSTRY